Von Willebrand disease overview: Difference between revisions

Jump to navigation Jump to search
Line 8: Line 8:




'''Von Willebrand disease''' (vWD) is the most common genetic coagulation disorder described in humans.  It affects up to 1% of the population, although most cases are mild.  Symptomatic vWD is much rare, ~1 in 10000.  Von Willebrand disease arises from a qualitative or quantitative deficiency of [[von Willebrand factor]] (vWF), a large glycoprotein protein that is required for [[platelet]]<nowiki/>s to bind to collagen.  vWF is therefore important in primary hemostasis.  When the disease comes to medical attention, it usually presents in the typical manner for platelet disorders: mucosal bleeding and easy bruising.  The disease is usually inherited in an autosomal dominant manner, although there are recessive forms as well, and it can also be acquired secondary to another disease.  <ref>Ng et al. Diagnostic Approach to von Willebrand Disease.  Blood 2015; 125(13): 2029-2037.</ref><ref>Blomback et al. Von Willebrand Disease Biology Hemophilia 2012; 18: 141-147.</ref><ref>Favarolo et al. Von Willebrand Disease and Platelet Disorders.  Hemophilia 2014; 20: 59-64.</ref>
Von Willebrand disease (vWD) is the most common genetic coagulation disorder described in humans.  It affects up to 1% of the population, although most cases are mild.  Symptomatic vWD is much rare, ~1 in 10000.  Von Willebrand disease arises from a qualitative or quantitative deficiency of [[von Willebrand factor]] ([[vWF]]), a large glycoprotein protein that is required for [[platelet]]<nowiki/>s to bind to collagen.  [[vWF]] is therefore important in primary hemostasis.  When the disease comes to medical attention, it usually presents in the typical manner for platelet disorders: mucosal bleeding and easy bruising.  The disease is usually inherited in an autosomal dominant manner, although there are recessive forms as well, and it can also be acquired secondary to another disease.  <ref>Ng et al. Diagnostic Approach to von Willebrand Disease.  Blood 2015; 125(13): 2029-2037.</ref><ref>Blomback et al. Von Willebrand Disease Biology Hemophilia 2012; 18: 141-147.</ref><ref>Favarolo et al. Von Willebrand Disease and Platelet Disorders.  Hemophilia 2014; 20: 59-64.</ref>


==References==
==References==

Revision as of 15:41, 28 November 2016

Von Willebrand disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Von Willebrand disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Von Willebrand disease overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Von Willebrand disease overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Von Willebrand disease overview

on Von Willebrand disease overview

Von Willebrand disease overview in the news

Blogs on Von Willebrand disease overview

Directions to Hospitals Treating Von Willebrand disease

Risk calculators and risk factors for Von Willebrand disease overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Von Willebrand’s disease is an genetic coagulation disorder with resultant abnormality in platelet adhesion and aggregation.


Von Willebrand disease (vWD) is the most common genetic coagulation disorder described in humans. It affects up to 1% of the population, although most cases are mild. Symptomatic vWD is much rare, ~1 in 10000. Von Willebrand disease arises from a qualitative or quantitative deficiency of von Willebrand factor (vWF), a large glycoprotein protein that is required for platelets to bind to collagen. vWF is therefore important in primary hemostasis. When the disease comes to medical attention, it usually presents in the typical manner for platelet disorders: mucosal bleeding and easy bruising. The disease is usually inherited in an autosomal dominant manner, although there are recessive forms as well, and it can also be acquired secondary to another disease. [1][2][3]

References

  1. Ng et al. Diagnostic Approach to von Willebrand Disease. Blood 2015; 125(13): 2029-2037.
  2. Blomback et al. Von Willebrand Disease Biology Hemophilia 2012; 18: 141-147.
  3. Favarolo et al. Von Willebrand Disease and Platelet Disorders. Hemophilia 2014; 20: 59-64.

Template:WH Template:WS